IP Verse

Ribociclib Tablet

Patent No. EP4197530 (titled "Ribociclib Tablet") was filed by Novartis on Apr 14, 2016. The application was issued on Nov 12, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ADALVOAug 12, 2026SLAVIK
STADA ARZNEIMITTELAug 12, 2026HAMM & WITTKOPP
GENERICS UKAug 11, 2026ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4197530

NOVARTIS
Application Number
EP22203730A
Filing Date
Apr 14, 2016
Status
Granted And Under Opposition
Oct 10, 2025
Publication Date
Nov 12, 2025
External Links
Slate, Register , Google Patents